Ligand Pharmaceuticals | Eigenkapital Und Reserven

Aktienkurs
204.34
Täglich Wechseln
1.79 0.88%
Monatlich
3.03%
Jährlich
77.29%
Q1 Prognose
192.24




Eigenkapital Und Reserven Veränderung Datum
Agenus USD -274.14M 80.46M 2025-09
Amgen USD 8.66B 961M 2025-12
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 568.42M 102.37M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Enviri Corporation USD 361.08M 15.18M 2025-09
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Glaxosmithkline GBP 21.7B 7.35B 2025-09
Heron Therapeutics USD 14.88M 42.14M 2025-09
Insmed USD 738.98M 206.6M 2025-12
Intrexon USD 43.17M 75.33M 2024-06
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
MacroGenics USD 67M 20.38M 2025-09
Merck USD 51.85B 2.79B 2025-09
Pacira USD 693.11M 34.1M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Veracyte USD 1.26B 36.61M 2025-09


Ligand Pharmaceuticals Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.